The technology of producing nylon 56 by bio-enzymatic method was independently developed by MBET, which has complete and independent intellectual property rights. Its unique technical route can significantly reduce the difficulty of purification in the post-process and improve the final product quality.

The integrated technology of MeiBang CPL ammoximation reaction separation is independently developed by MBET, and has complete and independent intellectual property rights. This technology has been applied on epsilon-caprolactam devices in China with a total of 2 million ton output.

The process of fluidized-bed hydrogen peroxide developed by MBET has the advantages of simple flow, stable process, good product quality and high production capacity every single-unit.

A double-effect recovery solution for caprolactam ammoximation tert-butanol with independent intellectual property rights by MBET, can effectively reduce the energy and steam consumption of the tert-butanol recovery system.

The caprolactam crystallization and purification technology developed by MBET has gained its own independent intellectual property rights. It can significantly improve product quality and reduce operating costs.

We are providing biocatalytic technology route development services for companies in chemical, medicine, food and other fields. We possesses biocatalyst bank screening, evolution, energy and coenzyme cycle and support of other advanced technology system platform. We can also provide commissioned technology development and technology transfer services.